OnKure Therapeutics (OKUR) Market Capitalization (2021 - 2026)

OnKure Therapeutics (OKUR) has reported Market Capitalization for 6 consecutive years, with $184.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 501.59% year-over-year to $184.7 million; the trailing twelve-month figure through Jun 2026 stood at $184.7 million (up 501.59% YoY), and the FY2025 full-year result was $39.7 million, down 65.45% from the prior year.
• Market Capitalization climbed to $184.7 million in Q2 2026 per OKUR's latest filing, from $56.6 million in the prior quarter.
• Across five years, Market Capitalization topped out at $1.0 billion in Q3 2023 and bottomed at $30.7 million in Q2 2025.
• Historically, Market Capitalization has averaged $241.4 million across 5 years, with a median of $98.5 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Market Capitalization soared 1248.93% in 2023, then plunged 84.76% in 2025.
• Over 5 years, Market Capitalization stood at $57.5 million in 2022, then jumped by 270.86% to $213.4 million in 2023, then plunged by 46.22% to $114.8 million in 2024, then slumped by 65.45% to $39.7 million in 2025, then surged by 365.69% to $184.7 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $184.7 million, $56.6 million, and $39.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.